MedPath

Acne Treatment With Active Oplon's Patches - 15-18 Years Old

Phase 2
Conditions
Acne Vulgaris
Registration Number
NCT01260766
Lead Sponsor
Oplon-Pure Science Ltd.
Brief Summary

The purpose of this study was to demonstrate the effect of short treatment with active OPLON patches on Acne.

Detailed Description

Patients with Acne Vulgaris were treated overnight with active patches. Effect is observed at the end of the treatment and 24 hours later.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Acne Vulgaris
  • Over 15 years
  • Signing informed consent
Exclusion Criteria
  • Active treatment of acne
  • Change in hormonal therapy
  • Antibiotic treatment in a week prior to the experiment
  • Sensitive skin
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Severity Score of lesionSeverity Score of lesion [Time Frame: 24 hours following patch removal]

Lesions were ranked by investigator according to severity whereas:

0-clear, 1-mild, 2-moderate, 3-sever

Secondary Outcome Measures
NameTimeMethod
Severity Score of lesionSeverity Score of lesion [Time Frame: 12 hours with the patch]

Lesions were ranked by investigator according to severity whereas:

0-clear, 1-mild, 2-moderate, 3-sever

Trial Locations

Locations (1)

Dermatology Clinic

🇮🇱

Natanya, Israel

Dermatology Clinic
🇮🇱Natanya, Israel
Avner Shemer, M.D.
Contact
+972-524575677
ashemer1@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.